DNS: Daiichi Sankyo Healthcare Acquires Leading Sports Nutrition Brand

Nippon Sangyo Suishin Kiko Ltd. (NSSK), a private equity firm known for its investment in promising Japanese companies, has announced the successful sale of the sports nutrition business of DNS Inc. (DNS) by NSSK II, a collective of investment partnerships managed by NSSK affiliates. This transaction marks the sale of DNS's renowned sports nutrition brand to Daiichi Sankyo Healthcare Co., Ltd. Established in 2000, DNS has grown to become one of Japan's leading sports nutrition brands, recognized for its protein powders developed through extensive research into athletes' nutritional needs and its collaboration with flavor experts. The meticulous manufacturing process of DNS, which includes anti-doping screenings, has established it as a safe and high-quality brand. Daiichi Sankyo Healthcare, part of a larger conglomerate with expertise in OTC drugs, skincare, oral care, and other consumer healthcare products, aims to integrate DNS into its product lines. The acquisition represents a strategic entry into the sports nutrition sector, aligning with Daiichi Sankyo Healthcare's mission to enhance individuals' health and quality of life. NSSK, driven by its investment strategy focused on superior returns and environmental, social, and governance goals, believes that Daiichi Sankyo Healthcare's expertise in R&D, product planning, and marketing will propel the DNS brand to new heights, furthering its value and reach.